Vulnerability During Infancy to Immunotoxic Contaminant Exposures
婴儿期对免疫毒性污染物暴露的脆弱性
基本信息
- 批准号:9885685
- 负责人:
- 金额:$ 53.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-04-01 至 2024-01-31
- 项目状态:已结题
- 来源:
- 关键词:5 year oldAdaptive Immune SystemAddressAdultAdverse effectsAffectAgeAge-MonthsAlgorithmsAmericanAntibiotic TherapyAntibodiesAntibody FormationAntibody ResponseAntigensAttenuatedAttenuated VaccinesBenchmarkingBirthBlood specimenBreast FeedingCell CountCellular PhoneChildChildhoodClinicalCohort StudiesCommunicable DiseasesConsensusDataDevelopmentDioxinsDiphtheriaDoseEnsureEnvironmental Risk FactorEquationExposure toFaeroe IslandsFrequenciesGuidelinesHaemophilus VaccinesHumanHuman MilkImmune systemImmunizationImmunologicsImmunosuppressionImmunotoxicologyImpairmentIncidenceIndividualInfantInfectionLeadLeukocytesLifeLinkLymphocyte SubsetMaternal antibodyMeasuresMediatingMediationMilkModelingMonitorMothersMultivariate AnalysisOrganismPneumococcal vaccinePolychlorinated BiphenylsPopulation StudyPreventionProteinsPublic HealthReportingResearchResistanceRiskRisk AssessmentRoleSamplingSeafoodSerumStatistical Data InterpretationStructureStudy modelsSystemSystems DevelopmentT-LymphocyteTechnologyTestingTetanusThymus GlandTimeToxic Environmental SubstancesToxoidsTranslatingUnited States Environmental Protection AgencyVaccinationVaccinesWorld Health Organizationantigen challengecohortcontaminated waterdrinking waterearly life exposureexposure pathwayimmune functionimmune system functionimmunotoxicityimprovedinfancyinsightmaternal serumnegative affectnovelpathogenpollutantpostnatalprenatalprospectiverecruitresponsesocioeconomicsvaccine efficacyvirtual
项目摘要
Abstract
Our studies have demonstrated that developmental exposure to perfluorinated alkylate substances (PFAS) are
associated with attenuated antibody responses to routine childhood vaccines. Our most recent findings
suggest that breastfeeding can transfer PFAS to the infant and lead to substantial elevations of serum-PFAS
concentrations, with possible adverse implications for immune system development. As blood samples from
infancy were not available to us in previous studies, we modeled the concentrations of early-life serum-PFAS
and showed that levels of early postnatal serum-PFAS are inversely associated with antibody concentrations
measured at age 5 years, more so than serum concentrations measured at age 18 months or later. The
present proposal will obtain blood samples in infancy and maternal milk for analysis of PFAS to improve the
modeling of profiles of serum-PFAS during infancy. This will allow testing of the hypothesis that early-life
exposure to immunotoxic PFAS impair the development of the adaptive immune system and negatively affects
the efficacy of routine childhood vaccines. The extended model of serum-PFAS will be used for estimation of
exposures of PFAS in infancy among >1,000 children from previous cohorts, where serum samples from
infancy were not collected. In addition to blood sampling at ages 3 and 12 months in the new cohort, we will
use novel cell phone technology to allow mothers to record breastfeeding, occurrence of infectious disease,
antibiotic treatment, and other relevant study parameters every two weeks. Our focus on vaccines will include
toxoids (diphtheria and tetanus), as these de novo protein vaccines are known to be the most reliable clinical
indicators of immune suppression. The duration of breastfeeding will be considered both as an exposure
pathway and a moderator, as breastfeeding is considered to be advantageous for the child’s immune system
development. The proposed study will be carried out at the Faroe Islands, where excellent conditions are
available to recruit the birth cohort and to ensure a high participation rate and minimal socioeconomic
confounding. Exposures of PFAS mainly originate from seafood and vary substantially, while average serum
concentrations are similar to U.S. levels. A cohort size of 600 can be recruited within 16 months and will
provide appropriate statistical power as one of the largest so far in the field. At 3 and 12 months of age,
vaccine antibodies, thymus size, and advanced differential white cell counts will be assessed. Statistical data
analysis will include multivariate analysis, assessment of mediation and/or modulation, structural equation
modeling of combined exposure of exposure associations of PFAS with immune functions, and benchmark
dose calculations. While research on immunotoxicology has traditionally focused on adverse effects in the
mature organism, this proposal aims to characterize immunotoxic risks from developmental exposure to these
priority pollutants at the most vulnerable developmental stages in early life.
摘要
我们的研究表明,发育过程中暴露于全氟烷化物质(PFAS)是
与对常规儿童疫苗的抗体反应减弱有关。我们最新的发现
提示母乳喂养可将PFAS传递给婴儿,并导致血清PFAS显著升高
浓度,可能对免疫系统发育产生不利影响。作为血液样本来自
在以前的研究中,我们无法获得婴儿期的数据,我们模拟了早期血清-PFAS的浓度
研究表明,出生后早期的血清-pfas水平与抗体浓度呈负相关。
在5岁时测量,比在18个月或更长时间测量的血清浓度更高。这个
目前的建议将采集婴儿和母亲母乳的血液样本进行全氟辛烷磺酸分析,以改善
婴儿期血清全氟辛烷酸谱的模拟。这将允许对早期生命的假设进行检验
暴露于免疫毒性全氟辛烷磺酸会损害适应性免疫系统的发育,并产生负面影响。
常规儿童疫苗的效力。扩展的血清-PFAS模型将用于估计
来自以前队列的1000名儿童在婴儿期暴露于PFAS,其中血清样本来自
婴儿没有被收集。除了在新的队列中对3岁和12个月大的婴儿进行血液采样外,我们还将
使用新颖的手机技术,让母亲可以记录母乳喂养,传染病的发生,
抗生素治疗,以及其他相关研究参数每两周一次。我们对疫苗的关注将包括
类毒素(白喉和破伤风),因为这些从头蛋白疫苗是已知的最可靠的临床疫苗
免疫抑制的指标。母乳喂养的持续时间将被视为
途径和调节剂,因为母乳喂养被认为对儿童的免疫系统有利
发展。拟议的研究将在法罗群岛进行,那里的条件很好
可用于招募出生队列,并确保高参与率和最低社会经济
令人困惑。全氟辛烷磺酸的暴露主要来自海鲜,差异很大,而平均血清
浓度与美国的水平相似。可以在16个月内招募600人的队列,并将
提供适当的统计力量,作为该领域迄今最大的之一。在3个月和12个月大的时候,
将对疫苗抗体、胸腺大小和高级分类白细胞计数进行评估。统计数据
分析将包括多变量分析、调节和/或调节的评估、结构方程
全氟辛烷磺酸暴露与免疫功能和基准的联合暴露模型
剂量计算。虽然免疫毒理学的研究传统上集中在
成熟的生物体,这项建议旨在表征发育过程中暴露于这些物质的免疫毒性风险
优先考虑生命早期最脆弱的发育阶段的污染物。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PHILIPPE ADAM GRANDJEAN其他文献
PHILIPPE ADAM GRANDJEAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PHILIPPE ADAM GRANDJEAN', 18)}}的其他基金
Vulnerability During Infancy to Immunotoxic Contaminant Exposures
婴儿期对免疫毒性污染物暴露的脆弱性
- 批准号:
10337281 - 财政年份:2020
- 资助金额:
$ 53.85万 - 项目类别:
Vulnerability During Infancy to Immunotoxic Contaminant Exposures
婴儿期对免疫毒性污染物暴露的脆弱性
- 批准号:
10737655 - 财政年份:2020
- 资助金额:
$ 53.85万 - 项目类别:
Assessment of PFAS exposures and health effects in two Massachusetts communities with PFAS drinking water contamination
评估马萨诸塞州两个受 PFAS 饮用水污染的社区的 PFAS 暴露和健康影响
- 批准号:
10021527 - 财政年份:2019
- 资助金额:
$ 53.85万 - 项目类别:
Assessment of PFAS exposures and health effects in two Massachusetts communities with PFAS drinking water contamination
评估马萨诸塞州两个受 PFAS 饮用水污染的社区的 PFAS 暴露和健康影响
- 批准号:
10471152 - 财政年份:2019
- 资助金额:
$ 53.85万 - 项目类别:
Assessment of PFAS exposures and health effects in two Massachusetts communities with PFAS drinking water contamination
评估马萨诸塞州两个受 PFAS 饮用水污染的社区的 PFAS 暴露和健康影响
- 批准号:
10220767 - 财政年份:2019
- 资助金额:
$ 53.85万 - 项目类别:
Assessment of PFAS exposures and health effects in two Massachusetts communities with PFAS drinking water contamination
评估马萨诸塞州两个受 PFAS 饮用水污染的社区的 PFAS 暴露和健康影响
- 批准号:
10268149 - 财政年份:2019
- 资助金额:
$ 53.85万 - 项目类别:
Assessment of PFAS exposures and health effects in two Massachusetts communities with PFAS drinking water contamination
评估马萨诸塞州两个受 PFAS 饮用水污染的社区的 PFAS 暴露和健康影响
- 批准号:
10441118 - 财政年份:2019
- 资助金额:
$ 53.85万 - 项目类别:
Inflammation and metabolic abnormalities in pollutant-exposed children
接触污染物的儿童的炎症和代谢异常
- 批准号:
9239171 - 财政年份:2017
- 资助金额:
$ 53.85万 - 项目类别:
Critical effects associated with developmental PFAS exposure profiles
与发育 PFAS 接触情况相关的关键影响
- 批准号:
10352511 - 财政年份:2017
- 资助金额:
$ 53.85万 - 项目类别:
Critical effects associated with developmental PFAS exposure profiles
与发育 PFAS 接触情况相关的关键影响
- 批准号:
10704011 - 财政年份:2017
- 资助金额:
$ 53.85万 - 项目类别:
相似海外基金
Single-cell analysis of adaptive immune system cells in IBD patients
IBD 患者适应性免疫系统细胞的单细胞分析
- 批准号:
22KJ2212 - 财政年份:2023
- 资助金额:
$ 53.85万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Antigen presentation to the adaptive immune system in the choroid contributes to ocular autoimmune disease
脉络膜中的适应性免疫系统的抗原呈递导致眼部自身免疫性疾病
- 批准号:
10740465 - 财政年份:2023
- 资助金额:
$ 53.85万 - 项目类别:
Elucidation of the adaptive immune system in teleost fish
阐明硬骨鱼的适应性免疫系统
- 批准号:
22K05824 - 财政年份:2022
- 资助金额:
$ 53.85万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Interaction of Galectin-9 and Pregnancy-Specific Glycoprotein 1 in the Regulation of Cells of the Innate and Adaptive Immune System
Galectin-9 和妊娠特异性糖蛋白 1 在先天性和适应性免疫系统细胞调节中的相互作用
- 批准号:
10434937 - 财政年份:2021
- 资助金额:
$ 53.85万 - 项目类别:
Peripheral Adaptive Immune System Changes Associated with Alzhiemer's Disease
与阿尔茨海默病相关的外周适应性免疫系统变化
- 批准号:
10194864 - 财政年份:2021
- 资助金额:
$ 53.85万 - 项目类别:
Interaction of Galectin-9 and Pregnancy-Specific Glycoprotein 1 in the Regulation of Cells of the Innate and Adaptive Immune System
Galectin-9 和妊娠特异性糖蛋白 1 在先天性和适应性免疫系统细胞调节中的相互作用
- 批准号:
10302501 - 财政年份:2021
- 资助金额:
$ 53.85万 - 项目类别:
Learning a molecular shape space for the adaptive immune system
学习适应性免疫系统的分子形状空间
- 批准号:
10275426 - 财政年份:2021
- 资助金额:
$ 53.85万 - 项目类别:
CAREER: Emergence of Functional Organization in the Adaptive Immune System
职业:适应性免疫系统中功能组织的出现
- 批准号:
2045054 - 财政年份:2021
- 资助金额:
$ 53.85万 - 项目类别:
Continuing Grant
Learning a molecular shape space for the adaptive immune system
学习适应性免疫系统的分子形状空间
- 批准号:
10669709 - 财政年份:2021
- 资助金额:
$ 53.85万 - 项目类别:
Learning a molecular shape space for the adaptive immune system
学习适应性免疫系统的分子形状空间
- 批准号:
10467050 - 财政年份:2021
- 资助金额:
$ 53.85万 - 项目类别: